Mon.Jan 15, 2024

article thumbnail

Nearly half of pharmacies sold to first-time buyers, reveals broker

The Pharmacist

First-time buyers made up 45% of pharmacy sales brokered by business property advisor Christie & Co in the last year, it has revealed in its latest annual report. And 55% of pharmacies were sold to independent contractors and regional multiple operators, Christie & Co said. The rise in first-time buyers is almost double the number […] The post Nearly half of pharmacies sold to first-time buyers, reveals broker appeared first on The Pharmacist.

111
111
article thumbnail

The Most Engaging Decision You’ll Read All Year – Five Stars

FDA Law Blog: Biosimilars

By David B. Clissold & Sara W. Koblitz — You know a court decision is going to be worth reading when the judges compare FDA’s regulatory governance of flavored e-cigarettes to a Shakespearean gaslighting. To quote the Fifth Circuit: “It was the regulatory equivalent of Romeo sending Mercutio on a wild goose chase—and then admitting there never was a goose while denying he even suggested the chase.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Keytruda Granted Latest FDA Approval in Cervical Cancer

Pharmaceutical Commerce

FDA approves Keytruda (pembrolizumab) combined with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer, which is the 39th overall approved indication for the drug in the United States.

107
107
article thumbnail

MHRA approves ‘safer’ medicine alternative for rare disease

European Pharmaceutical Review

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Agamree ® (vamorolone), as a safer alternative to corticosteroids, for Duchenne muscular dystrophy (DMD). “In addition to its anti-inflammatory efficacy, both the EMA and the MHRA recognise the benefits of treatment with Agamree for bone health and growth,” Dr Shabir Hasham, Chief Medical Officer of Santhera Pharmaceuticals shared.

105
105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

AI could revolutionise pharma compound synthesis

pharmaphorum

Researchers at the University of Cambridge and Pfizer have developed an AI-powered approach to make it easier to design and make pharma molecules

article thumbnail

Pharmacies urged to boost ambulatory blood pressure monitoring

The Pharmacist

Pharmacies offering the new Hypertension Case-Finding Service need to focus on converting more patients to ambulatory blood pressure monitoring (ABPM), according to a recent webinar by Community Pharmacy England (CPE). The service, relaunched on 1 December 2023, now requires contractors to have an ABPM device as well as their clinic meter. The CPE webinar, which […] The post Pharmacies urged to boost ambulatory blood pressure monitoring appeared first on The Pharmacist.

More Trending

article thumbnail

Could plastic alternative support environmentally-sustainable drug delivery?

European Pharmaceutical Review

The natural polymer tara gum polysaccharide ( Caesalpinia spinosa ) has application potential in pharmaceutical drug delivery , according to researchers in Korea. This is mainly due to its benefits such as its biocompatibility, biodegradability, and safety. A biodegradable alternative A study by the researchers, published in Carbohydrate Polymers , suggested that the material could be a natural, environmentally-friendly alternative to petroleum-based polymers such as plastic.

98
article thumbnail

As Novartis backs off, Amgen said to be after Cytokinetics

pharmaphorum

Speculation about a takeover play for Cytokinetics isn’t going away, with Amgen the latest company to be linked to the company and its highly-anticipated cardiovascular drug aficamten.

109
109
article thumbnail

Aversa Fentanyl combines abuse-deterrent transdermal technology with fentanyl patch system

Outsourcing Pharma

Access to opioids such as fentanyl can lead to abuse but now two companies have signed an agreement to reduce the abuse potential while making sure they are still accessible to those who need them.

88
article thumbnail

Santhera debuts DMD drug Agamree in Germany

pharmaphorum

Santhera’s new treatment for Duchenne muscular dystrophy Agamree has been launched in its first market, Germany, following its EU approval last month.

105
105
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

CellVoyant secures £7.6 million AI stem cell boost

Pharma Times

CellVoyant’s platform combines AI with live cell imaging

131
131
article thumbnail

Keytruda breaks new ground in cervical cancer

pharmaphorum

MSD’s Keytruda has been cleared by the FDA as the first PD-1 inhibitor for newly diagnosed cervical cancer patients with less severe disease

115
115
article thumbnail

Kanabo and City Dock Pharmacy team up

Pharma Times

Companies collaborate to launch walk-in pain clinic

128
128
article thumbnail

German union will resist any plan to split up Bayer

pharmaphorum

Germany’s IG BCE trade union has pushed back against any break-up of Bayer, claiming it could put thousands of domestic jobs at risk

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Accelerating how new drugs are made with machine learning

World Pharma News

Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could accelerate the design process for new drugs. Predicting how molecules will react is vital for the discovery and manufacture of new pharmaceuticals, but historically this has been a trial-and-error process, and the reactions often fail.

85
article thumbnail

True innovation in life sciences is only possible through a connected, pan-European approach

pharmaphorum

True innovation in life sciences is only possible through a connected, pan-European approach Mike.

111
111
article thumbnail

Cormica Bradford expanding equipment range to update capabilities

Outsourcing Pharma

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

83
article thumbnail

Boan Biotech completes enrolment for phase 3 study of Denosumab

Pharmafile

Boan Biotech has announced that it has completed subject enrolment for its international multicentre comparative phase 3 clinical trial of the company’s Denosumab injections (BA6101 and BA1102). The study will take place in Europe, the US and Japan, with a meeting having recently been held in Germany to share results from a phase 1 pharmacokinetic […] The post Boan Biotech completes enrolment for phase 3 study of Denosumab appeared first on Pharmafile.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

SGD Pharma to grow significantly in 2024 with investments and in package manufacturing

Outsourcing Pharma

SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging.

article thumbnail

Which pharmaceutical companies have the most injectable dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most injectable dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most injectable dosed drugs… The post Which pharmaceutical companies have the most injectable dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Cormica Bradford expanding equipment range to update capabilities

Outsourcing Pharma

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

81
article thumbnail

New patent expiration for Bausch And drug PROLENSA

Drug Patent Watch

Annual Drug Patent Expirations for PROLENSA Prolensa is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from two suppliers. There are nine… The post New patent expiration for Bausch And drug PROLENSA appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Aversa Fentanyl combines abuse-deterrent transdermal technology with fentanyl patch system

Outsourcing Pharma

Access to opioids such as fentanyl can lead to abuse but now two companies have signed an agreement to reduce the abuse potential while making sure they are still accessible to those who need them.

59
article thumbnail

New patent for Bioxcel drug IGALMI

Drug Patent Watch

Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are six patents protecting… The post New patent for Bioxcel drug IGALMI appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

pharmaphorum

Artificial intelligence (AI) is transforming the healthcare industry, particularly in decision-making and therapeutic advancements. Learn how AI will revolutionise healthcare and impact future decision-making processes in this informative article.

59
article thumbnail

New patent expiration for Btcp Pharma drug LAZANDA

Drug Patent Watch

Annual Drug Patent Expirations for LAZANDA Lazanda is a drug marketed by Btcp Pharma and is included in one NDA. There are five patents protecting this drug. This drug has… The post New patent expiration for Btcp Pharma drug LAZANDA appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Orion buys stake in LegoChem amid pivot to cancer and pain

pharmaphorum

Orion buys stake in LegoChem amid pivot to cancer and pain Phil.

105
105
article thumbnail

New patent for Sumitomo Pharma drug ORGOVYX

Drug Patent Watch

Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Sumitomo Pharma and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent for Sumitomo Pharma drug ORGOVYX appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

ixlayer Becomes Member of American Heart Association Center for Health Technology & Innovation Consortium

Pharmaceutical Commerce

The group—known as the Innovators' Network—is meant to serve as a link between entrepreneurs, providers, researchers, and payers while they strive to combat cardiovascular disease.

52
article thumbnail

New patent for Amicus Therap drug GALAFOLD

Drug Patent Watch

Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. It is available from one supplier. There are fifty-four… The post New patent for Amicus Therap drug GALAFOLD appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

How ProxsysRx Quadrupled One 340B Entity’s Savings & Revenue In A Single Quarter

Proxsys Rx

In late 2022, ProxsysRx’s team initiated 340B Program-Management support for a 198-bed, full-service, community and regional non-profit medical center located in the Northeast. After weeks of laying all the necessary groundwork to manage its 340B program, we began actively submitting eligible prescriptions this past January. By the end of Q1, the hospital’s 2023 340B savings & revenue had surpassed its total for all of 2022.